Authors: Wu S et al.
Anesthesiology 144(4):926–942, April 2026
Summary:
This mechanistic study investigates how a specialized subset of primary sensory neurons regulates mechanical pain at the spinal level. Traditionally, dorsal root ganglion (DRG) neurons are viewed as excitatory and glutamatergic, but this study focuses on a subgroup that also produces γ-aminobutyric acid (GABA), enabling both inhibitory and excitatory signaling.
Using advanced techniques including optogenetics, chemogenetics, and electrophysiology in mouse models, the authors demonstrated that these Vgat-positive sensory neurons form a dual-function circuit. They directly inhibit pain-transmitting spinal interneurons while simultaneously activating inhibitory interneurons through glutamatergic signaling, creating a feedforward inhibitory system. This dual mechanism acts as a “gate,” preventing normal mechanical stimuli from being perceived as painful.
After nerve injury, this inhibitory system becomes impaired. Specifically, the direct inhibitory input weakens, leading to increased sensitivity to mechanical stimuli (allodynia). Importantly, experimentally reactivating these neurons restored inhibitory control and significantly reduced pain hypersensitivity in animal models.
These findings redefine the role of peripheral sensory neurons, showing they are not just passive transmitters of pain signals but active regulators of spinal pain processing. The study also highlights a potential therapeutic target—enhancing peripheral inhibitory signaling—to treat neuropathic pain.
Key Points:
- A subset of DRG neurons can both inhibit and modulate pain signaling
- These neurons use dual GABA and glutamate pathways to create a spinal “gate”
- Loss of this inhibitory control contributes to neuropathic pain
- Reactivating these neurons reduces mechanical hypersensitivity
- Suggests new peripheral targets for pain management
What You Should Know:
This flips the script on pain pathways. The problem in neuropathic pain may not just be too much signal—it’s a failure of the body’s built-in inhibition. Future therapies may focus on restoring this “gate” rather than just blocking pain signals.
We would like to thank Anesthesiology for allowing us to summarize and share this article.